Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 04-2026 | 01-2026 | 10-2025 | 07-2025 | 04-2025 | |
| Sales | 13,836 | 16,559 | 15,035 | 13,995 | 12,355 |
| Cost of Goods | 6,809 | 8,834 | 7,262 | 7,995 | 7,272 |
| Gross Profit | 7,027 | 7,725 | 7,773 | 6,000 | 5,083 |
| Operating Expenses | 8,358 | 8,835 | 7,850 | 7,522 | 7,362 |
| Operating Income | -522 | -276 | 185 | -527 | -2,007 |
| Other Income | 27 | 39 | 70 | 75 | 42 |
| Pre-tax Income | -495 | -237 | 255 | -452 | -1,965 |
| Income Tax | 172 | 42 | 18 | 14 | -130 |
| Net Income Continuous | -667 | -279 | 237 | -466 | -1,835 |
| Minority Interests | N/A | N/A | -31 | -30 | N/A |
| Net Income | $-728 | $-279 | $268 | $-436 | $-1,835 |
| EPS Basic Total Ops | -0.05 | -0.02 | 0.02 | -0.03 | -0.14 |
| EPS Basic Continuous Ops | -0.05 | -0.02 | 0.02 | -0.03 | -0.13 |
| EPS Diluted Total Ops | -0.05 | -0.02 | 0.02 | -0.03 | -0.12 |
| EPS Diluted Continuous Ops | -0.05 | -0.02 | 0.02 | -0.03 | -0.13 |
| EPS Diluted Before Non-Recurring Items | -0.05 | -0.02 | 0.02 | -0.03 | -0.13 |
| EBITDA(a) | $-201 | $65 | $542 | $-169 | $-1,613 |